Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C

J. Hadziyannis, Stephanos; Sette, Hoel; R. Morgan, Timothy; Balan, Vijayan; Diago, Moises; Marcellin, Patrick; Ramadori, Giuliano; Bodenheimer, Henry; Bernstein, David; Rizzetto, Mario; Zeuzem, Stefan; J. Pockros, Paul; Lin, Amy; M. Ackrill, Andrew; the PEGASYS International Study Group*, for

doi:10.7326/0003-4819-140-5-200403020-00010

Public

Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C

Published in Annals of Internal Medicine • Mar 2, 2004

Authors:

Stephanos J. Hadziyannis

Hoel Sette

Timothy R. Morgan

Abstract

BACKGROUND: Treatment with pegylated interferon (peginterferon) and ribavirin for 48 weeks is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C. OBJECTIVE: To assess the efficacy and safety of 24 or 48 weeks of treatment with peginterferon-alpha2a plus a ...

Subject

Ribavirin

Medicine

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!